390 related articles for article (PubMed ID: 15357951)
21. CD28/CTLA-4--CD80/CD86 and ICOS--B7RP-1 costimulatory pathway in bronchial asthma.
Chen YQ; Shi HZ
Allergy; 2006 Jan; 61(1):15-26. PubMed ID: 16364152
[TBL] [Abstract][Full Text] [Related]
22. [CD28/B7 costimulating signal and its clinical significance].
Qu MH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):265-7. PubMed ID: 12513801
[TBL] [Abstract][Full Text] [Related]
23. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28.
Saito K; Sakurai J; Ohata J; Kohsaka T; Hashimoto H; Okumura K; Abe R; Azuma M
J Immunol; 1998 May; 160(9):4225-31. PubMed ID: 9574523
[TBL] [Abstract][Full Text] [Related]
24. A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity.
Chakrabarti R; Zhou ZF; Chang Y; Prud'homme GJ
Vaccine; 2005 Aug; 23(37):4553-64. PubMed ID: 15919138
[TBL] [Abstract][Full Text] [Related]
25. Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4.
Höllsberg P; Scholz C; Anderson DE; Greenfield EA; Kuchroo VK; Freeman GJ; Hafler DA
J Immunol; 1997 Nov; 159(10):4799-805. PubMed ID: 9366404
[TBL] [Abstract][Full Text] [Related]
26. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors.
Greenfield EA; Howard E; Paradis T; Nguyen K; Benazzo F; McLean P; Höllsberg P; Davis G; Hafler DA; Sharpe AH; Freeman GJ; Kuchroo VK
J Immunol; 1997 Mar; 158(5):2025-34. PubMed ID: 9036945
[TBL] [Abstract][Full Text] [Related]
27. T-cell regulation by CD28 and CTLA-4.
Alegre ML; Frauwirth KA; Thompson CB
Nat Rev Immunol; 2001 Dec; 1(3):220-8. PubMed ID: 11905831
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases.
Matsui T; Kurokawa M; Kobata T; Oki S; Azuma M; Tohma S; Inoue T; Yamamoto K; Nishioka K; Kato T
J Immunol; 1999 Apr; 162(7):4328-35. PubMed ID: 10201965
[TBL] [Abstract][Full Text] [Related]
29. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.
Kearney ER; Walunas TL; Karr RW; Morton PA; Loh DY; Bluestone JA; Jenkins MK
J Immunol; 1995 Aug; 155(3):1032-6. PubMed ID: 7543510
[TBL] [Abstract][Full Text] [Related]
30. T-cell stimulation: an abundance of B7s.
Abbas AK; Sharpe AH
Nat Med; 1999 Dec; 5(12):1345-6. PubMed ID: 10581066
[No Abstract] [Full Text] [Related]
31. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions.
Greene JL; Leytze GM; Emswiler J; Peach R; Bajorath J; Cosand W; Linsley PS
J Biol Chem; 1996 Oct; 271(43):26762-71. PubMed ID: 8900156
[TBL] [Abstract][Full Text] [Related]
32. Positive and negative regulation of human T cell activation mediated by the CTLA-4/CD28 ligand CD80.
Boulougouris G; McLeod JD; Patel YI; Ellwood CN; Walker LS; Sansom DM
J Immunol; 1998 Oct; 161(8):3919-24. PubMed ID: 9780158
[TBL] [Abstract][Full Text] [Related]
33. Immunology. The immunological synapse--a multitasking system.
van Der Merwe PA; Davis SJ
Science; 2002 Feb; 295(5559):1479-80. PubMed ID: 11859183
[No Abstract] [Full Text] [Related]
34. Synovium infiltrating T cells induce excessive synovial cell function through CD28/B7 pathway in patients with rheumatoid arthritis.
Shimoyama Y; Nagafuchi H; Suzuki N; Ochi T; Sakane T
J Rheumatol; 1999 Oct; 26(10):2094-101. PubMed ID: 10529123
[TBL] [Abstract][Full Text] [Related]
35. NK cell triggering by the human costimulatory molecules CD80 and CD86.
Wilson JL; Charo J; Martín-Fontecha A; Dellabona P; Casorati G; Chambers BJ; Kiessling R; Bejarano MT; Ljunggren HG
J Immunol; 1999 Oct; 163(8):4207-12. PubMed ID: 10510357
[TBL] [Abstract][Full Text] [Related]
36. Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation.
Darlington PJ; Kirchhof MG; Criado G; Sondhi J; Madrenas J
J Immunol; 2005 Jul; 175(2):996-1004. PubMed ID: 16002699
[TBL] [Abstract][Full Text] [Related]
37. The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion.
Rennert P; Furlong K; Jellis C; Greenfield E; Freeman GJ; Ueda Y; Levine B; June CH; Gray GS
Int Immunol; 1997 Jun; 9(6):805-13. PubMed ID: 9199963
[TBL] [Abstract][Full Text] [Related]
38. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
[TBL] [Abstract][Full Text] [Related]
39. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
[TBL] [Abstract][Full Text] [Related]
40. Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells.
Lazetic S; Leong SR; Chang JC; Ong R; Dawes G; Punnonen J
J Biol Chem; 2002 Oct; 277(41):38660-8. PubMed ID: 12167647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
